A Gamified Satellite Symposium during the IASLC 2022 World Conference on Lung Cancer (WCLC)
Sunday, 7 August 2022
18:00 – 19:00
Snacks and Refreshments will be provided
Mess Wien Exhibition & Congress Center
Hall C7
Messepl. 1, 1021
Wien, Austria
You must be registered for WCLC 2022 to attend this symposium.
FACULTY
Jared M. Weiss, MD
Professor, Medicine
Lineberger Comprehensive
The University of North Carolina at Chapel Hill
Chapel Hill, United States
Prof. MUDr. Aleš Ryška, MD, PhD
Head, Fingerland Department
Charles University Medical Faculty
Hradec Králové University Hospital
Prague, Czech Republic
Mihaela Aldea, MD, PhD
Associate Professor, Medical Oncology
Paris-Saclay University
Gustave Roussy
Villejuif, France
Join us in Vienna for the first ever Clinical OlympicsSM to be held during IASLC! Attendees will join 1 of 3 teams to compete in a series of Clinical Events, answering challenge questions - via iPad - on immunotherapy in non-small cell lung cancer (NSCLC). Individual learners will earn points for their chosen country with correct responses in each event. After each team competition is completed, and at the conclusion of the overall symposium, a Team Leader Board will appear on the big screens to show comparative scores across teams as the Gold, Silver, and Bronze medals are awarded for each event and for all-around performance in the Clinical OlympicsSM.
The treatment landscape for advanced NSCLC continues to rapidly evolve with the advent of newly targetable driver mutations and an ever-expanding plethora of immunotherapeutic regimens. In this symposium, participants will join an esteemed panel to receive expert insights — in an interactive, gamified manner — on evidence-based strategies for biomarker testing, optimal selection of checkpoint inhibitor regimens, and toxicity management.
PROGRAM AGENDA
Jared M. Weiss, MD
Use of Biomarker Testing in Advanced NSCLC
Prof. MUDr. Aleš Ryška, MD, PhD
Selecting Frontline Immunotherapy in Advanced NSCLC
Jared M. Weiss, MD
Managing Immunotherapy-Related Adverse Events in NSCLC
Mihaela Aldea, MD, PhD
Jared M. Weiss, MD
WHO SHOULD ATTEND?
Medical oncology and pulmonology clinicians managing patients with advanced NSCLC.
LEARNING OBJECTIVES FOR ATTENDEES
Upon completion of this symposium, learners should be better able to:
- Utilize molecular testing in patients with advanced non-small cell lung cancer (NSCLC) as a guide for frontline treatment selection
- Select optimal frontline immune checkpoint inhibitor regimens in appropriate patients with advanced NSCLC
- Manage potential immune-related adverse events in patients with advanced NSCLC receiving first-line immunotherapy
PROVIDER STATEMENT
This educational activity was independently developed by RMEI Medical Education, LLC. All faculty and planner relevant financial relationships were identified and mitigated and RMEI Medical Education, LLC has reviewed the content and determined it to be fair, balanced, and without commercial bias.
SUPPORTER STATEMENT
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.
Disclosure of Financial Relationships
RMEI Medical Education, LLC (RMEI) requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to RMEI policy. RMEI will disclose to learners the presence or absence of relevant financial relationships for all persons in control of content before the learner engages in the education.
FEE INFORMATION
There is no fee for this educational activity.
This program was approved by the IASLC 2022 World Conference on Lung Cancer Program Committee as an independent activity held in conjunction with the IASLC 2022 World Conference on Lung Cancer. This program is not sponsored or endorsed by IASLC and is not part of the official IASLC accredited program.
FOLLOW RMEI
Additional educational activities offered by RMEI Medical Education, LLC can be found
at www.RMEI.com or by calling toll-free (866) 770-RMEI.